ELMWOOD PARK, N.J.--(BUSINESS WIRE)--The Regulatory Harmonization Institute, Inc. (RHI) an international, not-for-profit association dedicated to global harmonization of drug and medical device regulatory requirements, today announced the launch of its Web site, programs and initiatives to affect the development and introduction of meaningful therapies to patients worldwide. Members include government organizations, public/private companies, patient advocacy organizations, not-for-profit entities, academic professionals and other industry groups.
